靶向MALAT1/PARP1/LIG3复合物诱导多发性骨髓瘤DNA损伤与凋亡
研究显示MALAT1在意义未明单克隆丙种球蛋白病(MGUS)和多发性骨髓瘤(MM)患者的骨髓浆细胞中表达升高,并通过结合PARP1和LIG3参与替代性非同源末端连接(A-NHEJ)通路。在MM细胞中降解MALAT1 RNA可刺激核蛋白多聚ADP核糖基化、损伤DNA修复通路并促发凋亡;抗MALAT1治疗与PARP1抑制剂或蛋白酶体抑制剂联用在体外显示协同效应。研究还用单壁碳纳米管(SWCNT)偶联抗MALAT1寡核苷酸在培养MM细胞系和异种移植小鼠模型中成功敲低MALAT1 RNA,并在体内诱导DNA损伤和细胞凋亡,提示MALAT1可能作为MM治疗的潜在新靶点。
要点
- MGUS和MM患者骨髓浆细胞表达升高的MALAT1,且通过结合PARP1和LIG3参与A-NHEJ通路。
- 反义gapmer寡核苷酸经RNase H降解MALAT1 RNA可刺激核蛋白多聚ADP核糖基化、损伤DNA修复并促凋亡。
- 抗MALAT1治疗与PARP1抑制剂或蛋白酶体抑制剂联用在MM细胞体外显示协同效应。
核心结论
- MALAT1在多发性骨髓瘤DNA修复和细胞死亡中发挥重要作用,可能作为MM治疗的潜在新靶点。
研究设计与样本
- 研究检测了MGUS和MM患者骨髓浆细胞的MALAT1表达及A-NHEJ通路参与情况。
- 在MM细胞中使用反义gapmer DNA寡核苷酸经RNase H降解MALAT1 RNA,并评估DNA修复和凋亡。
- 使用单壁碳纳米管(SWCNT)偶联抗MALAT1寡核苷酸在培养MM细胞系和异种移植小鼠模型中敲低MALAT1 RNA。
主要发现
- MGUS和MM患者骨髓浆细胞表达升高的MALAT1,并通过结合PARP1和LIG3参与A-NHEJ通路。
- 在MM细胞中降解MALAT1 RNA刺激核蛋白多聚ADP核糖基化、损伤DNA修复通路并促发凋亡通路。
- 抗MALAT1治疗联合PARP1抑制剂或蛋白酶体抑制剂在MM细胞体外显示协同效应。
- SWCNT偶联抗MALAT1寡核苷酸在培养MM细胞系和异种移植小鼠模型中成功敲低MALAT1 RNA。
- 抗MALAT1治疗在体内诱导DNA损伤和细胞凋亡。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Metastasis-associated lung adenocarcinoma transcript 1 (MALAT1) is a highly conserved long non-coding RNA (lncRNA). Overexpression of MALAT1 has been demonstrated to related to poor prognosis of multiple myeloma (MM) patients. Here, we demonstrated that MALAT1 plays important roles in MM DNA repair and cell death. We found bone marrow plasma cells from patients with monoclonal gammopathy of undetermined significance (MGUS) and MM express elevated MALAT1 and involve in alternative non-homozygous end joining (A-NHEJ) pathway by binding to PARP1 and LIG3, two key components of the A-NHEJ protein complex. Degradation of the MALAT1 RNA by RNase H using antisense gapmer DNA oligos in MM cells stimulated poly-ADP-ribosylation of nuclear proteins, defected the DNA repair pathway, and further provoked apoptotic pathways. Anti-MALAT1 therapy combined with PARP1 inhibitor or proteasome inhibitor in MM cells showed a synergistic effect in vitro. Furthermore, using novel single-wall carbon nanotube (SWCNT) conjugated with anti-MALAT1 oligos, we successfully knocked-down MALAT1 RNA in cultured MM cell lines and xenograft murine models. Most importantly, anti-MALAT1 therapy induced DNA damage and cell apoptosis in vivo, indicating that MALAT1 could serve as a potential novel therapeutic target for MM treatment.
引用
- Hu Y, Lin J, Fang H, et al. Targeting the MALAT1/PARP1/LIG3 complex induces DNA damage and apoptosis in multiple myeloma. Leukemia. 2018. PMID: 29632340. doi:10.1038/s41375-018-0104-2
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。